Research Program Partners

HomeProfessionalsResearch ▶ Research Program Partners
ATS Foundation Research Program Partners

The ATS Foundation Research Program is extremely grateful to our partners in research. A guiding principle of the Research Program is to collaborate with other medical, research, clinical, professional, corporate, patient, and non-profit organizations that are focused on the diagnosis, understanding, and treatment of lung disease.

Special thanks to our partners funding a research grant starting in 2017!

alpha1
ALAMP
ResMed


Our research partners sharing research priorities and funding responsibilities are:

Aerocrine, Inc.
Alliance for Academic Internal Medicine
Alpha-1 Foundation*
American Lung Association
American Lung Association of Hawaii
American Lung Association of the Mountain Pacific
American Society of Transplantation
ATS Foundation Tobacco-Dependence Research Fund
ARDS Foundation*
Association of Specality Professors
Asthma and Allergy Foundation of America*
Boehringer-Ingelheim Pharmaceuticals, Inc.
Breathe California of Los Angeles
Children’s Interstitial Lung Disease Foundation* 
Coalition for Pulmonary Fibrosis
COPD Foundation
Cystic Fibrosis Foundation*
Emphysema Fighting for Our Right to Survive
Foundation for Sarcoidosis Research*
Genentech
Hermansky-Pudlak Syndrome Network
The LAM Foundation*
LAM Treatment Alliance
LUNGevity Foundation
Merck, Inc.
The Nathan Cummings Foundation
Pfizer, Inc.
Primary Ciliary Dyskinesia (PCD) Foundation* 
Pulmonary Fibrosis Foundation
Pulmonary Hypertension Association
ResMed
Respiratory Health Association of Metropolitan Chicago
Respironics Foundation
Sarcoidosis Research Institute
Scleroderma Foundation*
Sepsis Alliance
Veterans Administration

* Current members of the ATS Public Advisory Roundtable (PAR)
For more information about ATS PAR, please click here

Interested in becoming a Research Program Partner?
Email researchprogram@thoracic.org for more information.

Last Reviewed: May 2017